Last update 08 May 2025
River 2 Renal Corp.

River 2 Renal Corp.

Private Company|2020|New York, United States

Overview

Basic Info

Introduction
River 2 Renal Corp., a creator of innovative treatments aimed at eradicating rare diseases, was founded on October 27, 2020. Presently, the company's status is listed as Inactive. River 2 Renal Corp. ceased operations on January 26, 2023, after actively running for a period of two years, two months, and thirty days from the time it was set up till its closure.

Tags

Digestive System Disorders
Cardiovascular Diseases
Urogenital Diseases
Synthetic peptide

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Synthetic peptide1
Top 5 TargetCount
RXFP1(Relaxin receptor 1)1

Related

1
Drugs associated with River 2 Renal Corp.
R2R01
Target
RXFP1
Mechanism
RXFP1 agonists
Active Org.
River 2 Renal Corp.River 2 Renal Corp. [+1]
Originator Org.
River 2 Renal Corp.River 2 Renal Corp.
Active Indication
Heart Failure [+4]
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
3
Clinical Trials associated with River 2 Renal Corp.
NCT06264310
/ CompletedPhase 2
A Phase 2, Double-Blind, Placebo-Controlled, Dose Range Finding Study to Assess Safety, Tolerability, Efficacy and Pharmacokinetics of the Relaxin Agonist R2R01 Combined With Standard of Care Versus Standard of Care Alone in Outpatients With Worsening Heart Failure (WHF)
NCT05875948
/ RecruitingPhase 2
A Single-blind, Phase 2, Multi-center, Randomized Study to Assess Safety, Tolerability, Efficacy and Pharmacokinetics of the R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome - Acute Kidney Injury
NL-OMON51081
/ CompletedNot Applicable
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Ranging Study in Healthy Volunteers to Assess Safety, Tolerability, and Evaluate the Pharmacokinetics and Pharmacodynamics of R2R01 - Placebo-controlled SAD/MAD of R2R01
100 Clinical Results associated with River 2 Renal Corp.
Login to view more data
0 Patents (Medical) associated with River 2 Renal Corp.
Login to view more data
100 Deals associated with River 2 Renal Corp.
Login to view more data
100 Translational Medicine associated with River 2 Renal Corp.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 21 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
R2R01
 ( RXFP1 )		Acute Kidney Injury
More
Phase 2
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free